Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950123-06-003431
Filing Date
2006-03-20
Accepted
2006-03-20 17:31:09
Documents
9
Group Members
E MERCK OHG

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D y18785sc13d.htm SC 13D 67621
2 EX-99.1: JOINT FILING AGREEMENT y18785exv99w1.htm EX-99.1 3128
3 EX-99.2: AGREEMENT RELATING TO THE CREDIT FACILITY y18785exv99w2.htm EX-99.2 1007037
4 EX-99.3: PRESS RELEASE y18785exv99w3.htm EX-99.3 21730
5 EX-99.4: PUBLICATION OF DECISION TO MAKE A TAKEOVER OFFER y18785exv99w4.htm EX-99.4 7362
6 EX-99.5: AD-HOC NOTIFICATION y18785exv99w5.htm EX-99.5 5254
7 GRAPHIC y18785y1878501.gif GRAPHIC 1740
8 GRAPHIC y18785y1878502.gif GRAPHIC 1200
9 GRAPHIC y18785y1878503.gif GRAPHIC 2202
  Complete submission text file 0000950123-06-003431.txt   1121430
Mailing Address 64271 DARMSTADT GERMANY I8 00000
Business Address 64271 DARMSTADT GERMANY HRB 6164 I8
MERCK KGAA /FI (Filed by) CIK: 0001004059 (see all company filings)

EIN.: 000000000
Type: SC 13D

Mailing Address MULLERSTRASSE 178 BERLIN FEDERAL REPUBLIC OF GERMANY BERLIN GERMANY I8 13353
Business Address MULLERSTRASSE 178 BERLIN FEDERAL REPUBLIC OF GERMANY BERLIN GERMANY I8 13353
SCHERING AKTIENGESELLSCHAFT (Subject) CIK: 0001124139 (see all company filings)

EIN.: 000000000
Type: SC 13D | Act: 34 | File No.: 005-59757 | Film No.: 06699517
SIC: 2834 Pharmaceutical Preparations